Sequoia Financial Advisors’s Pacific Biosciences PACB Stock Holding History

Sequoia Financial Advisors’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.7K	Buy	+31,355	New	+$45.6K	﹤0.01%	2124

Other funds holding PACB

Mirador Capital Partners Pleasanton, California $817M AUM 42.46% 1-Year Est. Return

Wealth Enhancement Advisory Services

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Bay Colony Advisors Concord, Massachusetts $903M AUM 33.67% 1-Year Est. Return

Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

LRI Investments Palm Beach Gardens, Florida $1.24B AUM 11.13% 1-Year Est. Return

Sequoia Financial Advisors's PACB Position: Q2 2026 in Review

Sequoia Financial Advisors opened a new position in Pacific Biosciences (PACB) in Q2 2026: 31,355 shares worth $52.7K. The stake represents ﹤0.01% of the portfolio and ranks #2124 among its holdings.

11 funds tracked by Wall St. Rank hold PACB as of Q2 2026.

Sequoia Financial Advisors held 31,355 shares of Pacific Biosciences worth $52.7K as of Q2 2026.
Pacific Biosciences was a new Sequoia Financial Advisors position in Q2 2026.
Pacific Biosciences made up ﹤0.01% of Sequoia Financial Advisors's portfolio in Q2 2026, its #2124 holding.
11 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.

Based on Sequoia Financial Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.